Meningococcal Vaccine Market

Mar 2021| MRS119A| Market Research Studies

Report Highlights

The report focused on the different types and brands of Meningococcal Vaccines. The report also focused on the affected age group by meningococcal infection. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for Meningococcal Vaccine market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each type, brand, age group, end-user and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Meningococcal Vaccine markets; it explains the major market drivers of the Global Meningococcal Vaccine industry, current trends within the industry, major applications, and the regional dynamics of the Global Meningococcal Vaccine Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Meningococcal Vaccine Market.

Report Includes

  • 41 tables and 49 figures
  • An up-to-date analysis of the Global Meningococcal Vaccine Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Meningococcal Vaccine Market, and corresponding market share analysis by type, brand, age group, end-user, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Meningococcal Vaccine, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new vaccines, and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Meningococcal Vaccine Market as compared to overall global economy.
  • Insight into the growth development strategies of major Meningococcal Vaccine manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG and others.

Summary

Meningococcal meningitis often referred to as, neisseria meningitidis is one a rare disease caused by severe bacterial infection. In this disease, the bacteria act upon the lining of spinal cord and brain which can cause severe damage as well as endemics. The transmission of the disease is possible either coming in direct contact with the infected person or by directly contacting respiratory or throat secretions of the infected person. According to the Centers for Disease Control and Prevention (CDC), every year around 1.2 million cases are registered for bacterial meningitis globally. The disease is highly fatal and can cause severe complications if the disease is left untreated. Meningococcal vaccines are used to prevent the meningococcal bacterial infection. Some of the common factors driving the global meningococcal vaccine market are increasing awareness among the population by setting up more awareness programs and production of cost-effective vaccines which are easily afforded by the patients. There are mainly two types of meningococcal vaccines which are widely used globally namely, bivalent and quadrivalent meningococcal vaccines.

The increasing number of meningitis patients is going to increase the demand of meningococcal vaccine market. Apart from that various industrial event such as, mergers and acquisitions, new product approvals, clinical trials and launch of new products is going to bolster the Global Meningococcal Vaccine Market.

The Global Meningococcal Vaccine Market was valued at $2.79 billion in 2020 and is expected to witness a steady growth at a CAGR of 9.3% during the forecast period.

  • Table 1 : Global Meningococcal Vaccine Market, Through 2026
  • Table 2 : Global Meningococcal Vaccine Market, by Type, Through 2026
  • Table 3 : Global Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 4 : Global Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 5 : Global Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 6 : Global Meningococcal Vaccine Market, by Region, Through 2026
  • Table 7 : North America Meningococcal Vaccine Market, by Type, Through 2026
  • Table 8 : North America Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 9 : North America Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 10 : North America Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 11 : North America Meningococcal Vaccine Market, by Country, Through 2026
  • Table 12 : Europe Meningococcal Vaccine Market, by Type, Through 2026
  • Table 13 : Europe Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 14 : Europe Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 15 : Europe Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 16 : Europe Meningococcal Vaccine Market, by Country, Through 2026
  • Table 17 : Asia-Pacific Meningococcal Vaccine Market, by Type, Through 2026
  • Table 18 : Asia-Pacific Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 19 : Asia-Pacific Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 20 : Asia-Pacific Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 21 : Asia-Pacific Meningococcal Vaccine Market, by Country, Through 2026
  • Table 22 : South America Meningococcal Vaccine Market, by Type, Through 2026
  • Table 23 : South America Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 24 : South America Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 25 : South America Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 26 : South America Meningococcal Vaccine Market, by Country, Through 2026
  • Table 27 : Middle East & Africa Meningococcal Vaccine Market, by Type, Through 2026
  • Table 28 : Middle East & Africa Meningococcal Vaccine Market, by Brand, Through 2026
  • Table 29 : Middle East & Africa Meningococcal Vaccine Market, by Age Group, Through 2026
  • Table 30 : Middle East & Africa Meningococcal Vaccine Market, by End-User, Through 2026
  • Table 31 : Middle East & Africa Meningococcal Vaccine Market, by Country, Through 2026
  • Table 32 : Pfizer Inc.: Financial Performance, Through 2020
  • Table 33 : Sanofi S.A.: Financial Performance, Through 2020
  • Table 34 : Serum Institute of India Pvt. Ltd.: Financial Performance, Through 2020
  • Table 35 : GlaxoSmithKline plc: Financial Performance, Through 2020
  • Table 36 : Merck & Co., Inc.: Financial Performance, Through 2020
  • Table 37 : Novartis International AG: Financial Performance, Through 2020
  • Table 38 : Walvax Biotechnology Co., Ltd.: Financial Performance, Through 2020
  • Table 39 : Bio-Med Pvt. Ltd.: Financial Performance, Through 2020
  • Table 40 : Chongqing Zhifei Biological Products Company Ltd.: Financial Performance, Through 2020
  • Table 41 : Incepta Pharmaceuticals Ltd.: Financial Performance, Through 2020
  • Figure 1 : Global Meningococcal Vaccine Market
  • Figure 2 : Global Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 3 : Global Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 4 : Global Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 5 : Global Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 6 : Global Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 7 : Global Meningococcal Vaccine Market, by Value, by Region, 2020
  • Figure 8 : Global Meningococcal Vaccine Market, by Value, by Company, 2020
  • Figure 9 : Global Meningococcal Vaccine Market, Product Map, 2020
  • Figure 10 : North America Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 11 : North America Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 12 : North America Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 13 : North America Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 14 : North America Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 15 : North America Meningococcal Vaccine Market, by Value, by Country, 2020
  • Figure 16 : Europe Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 17 : Europe Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 18 : Europe Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 19 : Europe Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 20 : Europe Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 21 : Europe Meningococcal Vaccine Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 24 : Asia-Pacific Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 25 : Asia-Pacific Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 26 : Asia-Pacific Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 27 : Asia-Pacific Meningococcal Vaccine Market, by Value, by Country, 2020
  • Figure 28 : South America Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 29 : South America Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 30 : South America Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 31 : South America Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 32 : South America Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 33 : South America Meningococcal Vaccine Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Meningococcal Vaccine Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Meningococcal Vaccine Market, by Value, by Type, 2019-2026
  • Figure 36 : Middle East & Africa Meningococcal Vaccine Market, by Value, by Brand, 2019-2026
  • Figure 37 : Middle East & Africa Meningococcal Vaccine Market, by Value, by Age Group, 2019-2026
  • Figure 38 : Middle East & Africa Meningococcal Vaccine Market, by Value, by End-User, 2019-2026
  • Figure 39 : Middle East & Africa Meningococcal Vaccine Market, by Value, by Country, 2020
  • Figure 40 : Pfizer Inc.: Revenue Share, 2020
  • Figure 41 : Sanofi S.A.: Revenue Share, 2020
  • Figure 42 : Serum Institute of India Pvt. Ltd.: Revenue Share, 2020
  • Figure 43 : GlaxoSmithKline plc: Revenue Share, 2020
  • Figure 44 : Merck & Co., Inc.: Revenue Share, 2020
  • Figure 45 : Novartis International AG: Revenue Share, 2020
  • Figure 46 : Walvax Biotechnology Co., Ltd.: Revenue Share, 2020
  • Figure 47 : Bio-Med Pvt. Ltd.: Revenue Share, 2020
  • Figure 48 : Chongqing Zhifei Biological Products Company Ltd.: Revenue Share, 2020
  • Figure 49 : Incepta Pharmaceuticals Ltd.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report